Clinical Report: Modulating Macrophage Metabolism in Obesity-Related Disorders
Overview
This review discusses the role of macrophage metabolism in obesity and related metabolic disorders, highlighting their phenotypic plasticity and the impact of tissue microenvironments.
Background
Obesity is a significant global health issue, affecting over 1 billion individuals and contributing to various metabolic disorders such as type 2 diabetes and cardiovascular diseases. The interplay between immune responses and metabolism, termed 'immunometabolism,' is crucial in understanding the pathophysiology of obesity-related conditions. Macrophages, as key innate immune cells, play a pivotal role in this dynamic, influencing both inflammation and metabolic homeostasis.
Data Highlights
No specific numerical data or trial results were provided in the source material.
Key Findings
Macrophages exhibit phenotypic plasticity, influencing tissue homeostasis and disease progression.
Obesity leads to chronic low-grade inflammation, driven by macrophage infiltration and altered immune cell functions.
Macrophage polarization into M1 and M2 subsets is influenced by local microenvironmental signals.
Disruption of immune-metabolic homeostasis is a hallmark of obesity-related metabolic diseases.
Clinical Implications
Recognizing the role of macrophages in metabolic disorders can inform targeted therapeutic approaches.
Conclusion
The review emphasizes the importance of macrophage metabolism in the context of obesity and related metabolic disorders.
